Skip to content

Clinical trials

Metabolic Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: United Kingdom Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20091
20103
20134
20141
20153
20163
20173
20186
20193
20207
20215
20225
20233
20247
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting8
Recruiting7
Unknown status7
Terminated4
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
89bio, Inc.3
Alexion Pharmaceuticals, Inc.3
AstraZeneca2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Dr. Schär AG / SPA2
Imperial College London2
Kastle Therapeutics, LLC2
ModernaTX, Inc.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases61
Glucose Metabolism Disorders14
Metabolism, Inborn Errors14
Genetic Diseases, Inborn13
Diabetes Mellitus11
Diabetes Mellitus, Type 211
Endocrine System Diseases8
Lipid Metabolism Disorders7
Dyslipidemias6
Amino Acid Metabolism, Inborn Errors5

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.